SCHEMBL3154694

SCHEMBL3154694

COc1cc(CO)on1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7303479 0.82 NOTUM (0.43)
SCHEMBL18914801 0.81 TNKS2 (0.38)
SCHEMBL10283737 0.81
SCHEMBL26928299 0.80 NOTUM (0.44)
SCHEMBL10157733 0.79
SCHEMBL441859 0.79
SCHEMBL15290013 0.79
SCHEMBL3765497 0.79
SCHEMBL3154091 0.79
Hydrochloric Acid SCHEMBL440017 0.78 NOTUM (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3684773-B1 THAILANSTATIN ANALOGS PH PHARMA CO LTD (KR) 2026-04-29 EP disclosed
US-20240208992-A1 MACROCYCLES AS CFTR MODULATORS IDORSIA PHARMACEUTICALS LTD (CH) 2024-06-27 US disclosed
EP-4308575-A1 MACROCYCLES AS CFTR MODULATORS Idorsia Pharmaceuticals Ltd (CH) 2024-01-24 EP disclosed
CN-111788208-B Talarstatin analogues PH制药有限公司 2023-11-24 CN disclosed
CN-116981672-A Macrocyclic compounds as CFTR modulators 爱杜西亚药品有限公司 2023-10-31 CN disclosed
US-11691982-B2 Thailanstatin analogs PH PHARMA CO., LTD. (KR) 2023-07-04 US disclosed
US-11691982-B2 Thailanstatin analogs PH PHARMA CO., LTD. (KR) 2023-07-04 US disclosed
US-11691982-B2 Thailanstatin analogs PH PHARMA CO., LTD. (KR) 2023-07-04 US disclosed
WO-2022194399-A1 MACROCYCLES AS CFTR MODULATORS IDORSIA PHARMACEUTICALS LTD (CH) 2022-09-22 WO disclosed
US-20200407369-A1 THAILANSTATIN ANALOGS PH PHARMA CO., LTD. (KR) 2020-12-31 US disclosed
EP-0691962-A1 1-AMINO-3-PHENOXY PROPANE DERIVATIVES AS MODULATORS OF MULTI-DRUG RESISTANCE BASF AKTIENGESELLSCHAFT (DE) 1996-01-17 EP disclosed
US-5399696-A Excitatory amino acid receptor antagonists; nervous system disorders ELI LILLY AND COMPANY (US) 1995-03-21 US disclosed
WO-1994022842-A1 1-AMINO-3-PHENOXY PROPANE DERIVATIVES AS MODULATORS OF MULTI-DRUG RESISTANCE BASF AKTIENGESELLSCHAFT (DE) 1994-10-13 WO disclosed
EP-0590789-A1 Excitatory amino acid receptor antagonists ELI LILLY AND COMPANY (US) 1994-04-06 EP disclosed
US-5284957-A Substituted 1H- or 2H-tetrazoles ELI LILLY AND COMPANY (US) 1994-02-08 US disclosed
EP-0207955-B1 PROCESS FOR THE PREPARATION OF 3,5-DISUBSTITUTED ISOXAZOLES ZAMBON S.p.A. (IT) 1990-02-07 EP disclosed
US-4873243-A ANTIDEPRESSANTS OR PYCHOTONICS SANOFI (FR) 1989-10-10 US disclosed
US-4772719-A FROM DIHALOFORMALDOXIME AND ALKYNE, CYCLIZATION ZAMBON S.P.A. (IT) 1988-09-20 US disclosed
EP-0207955-A1 PROCESS FOR THE PREPARATION OF 3,5-DISUBSTITUTED ISOXAZOLES. ZAMBON SPA (IT) 1987-01-14 EP disclosed
WO-1986003490-A1 PROCESS FOR THE PREPARATION OF 3,5-DISUBSTITUTED ISOXAZOLES ZAMBON S.P.A. (IT) 1986-06-19 WO disclosed